Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

van Breemen, Richard B., Muchiri, Ruth N., Bates, Timothy A., Weinstein, Jules B., Leier, Hans C., Farley, Scotland, Tafesse, Fikadu G.·2022·Journal of Natural Products
DOI 10.1021/acs.jnatprod.1c00946

Cited by (135)

Items 101–135 of 135

  1. Modular Approach to In Silico Antiviral Multitargets Inhibitor: Molecular Dockings, Dynamics, Principal Component Analysis, Clustering, and Energy Landscape
    Suliman A. Almahmoud, Hamdoon Abdelhamid Mohammed, Minhajul Arfeen, Mostafa Mahmoud Hegazy, Devendra Kumar Dhaked, Ashish Srivastava, Faizul Azam, Riaz A. Khan · 2026 · ChemistrySelect
  2. Molecular Dynamics and Solvated Interaction Energy Prioritize Cannabidiol and Cannabinol as Variant-Spanning SARS-CoV-2 RBD–ACE2 Interface Blockers
    Napat Kongtaworn, Silpsiri Sinsulpsiri, Chonnikan Hanpaibool, Phornphimon Maitarad, Panupong Mahalapbutr, Thanyada Rungrotmongkol · 2026 · Molecules
  3. Cannabis sativa
    Priyanka Joshi Jain, Nikhil Rajnani, Nalini Kurup · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  4. Cannabinoid receptor subtype 2 (CB2R): Features and targets for medical applications
    Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, Francesco Leonetti, Angela Stefanachi · 2023 · Elsevier eBooks
  5. Plant metabolites for treating diseases
    Simone Ann Marie Badal, G.J. Miller, W. Matthew Sattley · 2023 · Elsevier eBooks
  6. "Crude Cannabis Extracts are More Potent than Mono- Substances in Inhibiting SARS-CoV-2 Entry"
    Rania Boulesbiaat · 2022 · Biomedical Journal of Scientific & Technical Research
  7. Prospecção Tecnológica sobre o Uso Medicinal de Cannabis sativa para Tratamento da Covid-19
    Carmem Luíza Sartório, Deize Pereira Alexandrino Dias Santos, Lívia Carla de Melo Rodrigues, Paulo José Lima Juíz · 2023 · Cadernos de Prospecção
  8. Riesgos inducidos por la mariguana recreativa vs. la utilidad de los cannabinoides en el COVID-19
    Andrea Herrera-Solís, Rodolfo Sánchez‐Zavaleta, Alejandra E. Ruiz‐Contreras, Jacqueline Cortés Morelos, Mónica Méndez‐Díaz, Oscar E. Prospero-Garcia · 2023 · Revista Internacional de Investigación en Adicciones
  9. Analysis Of The Inhibitory Ability Of Spike Attachment Of The Delta Variant Of Sars Cov-2 With Ace2 By The Active Compound In Turmeric (Curcuma longa L.) In Silico
    Pratasyah Liyaajul, Miftahul Mushlih, Chylen Setiyo Rini, Jamilatur Rohmah · 2023 · Medicra (Journal of Medical Laboratory Science/Technology)
  10. Get a Jab or Grab a Glass (of Wine): A Sentiment and Corpus-Assisted Discourse Analysis of Reader Comments on News Story in the Daily Mail
    Francesco Nacchia · 2023 · Lingue Culture Mediazioni - Languages Cultures Mediation (LCM Journal)
  11. Dual Engineering of Olivetolic Acid Cyclase and Tetraketide Synthase for the Formation of Longer Alkyl-Chain Olivetolic Acid Analogs and Their Antibacterial Activities
    Hiroyuki Morita · 2023 · Chemical and Pharmaceutical Bulletin
  12. Feasibility and Effective Binding Inhibitors against COVID-19 BA.2.86
    Toshihiko Hanai · 2024 · Journal of drug design and research.
  13. In vivo and in vitro assays, and safety profiles of cannabinoids
    Mayeso N.V. Gwedela, Collins Edward Jana, Tuntufye Mwambyale, Ibrahim Chikowe, Lifa Chimphepo, George Chirambo · 2024 · Elsevier eBooks
  14. Correlation between Chemical Fertilization Practices, Phytochemical Response, and Biological Activities of Cannabis sativa L.
    Marianela Simonutti, Gisela Marisol Seimandi, Geraldina Alicia Richard, Juan Marcelo Zabala, Marcos Derita · 2024 · Combinatorial Chemistry & High Throughput Screening
  15. THE ULTIMATE HERB CANNABIS FOR AFFECTING DISEASES
    2024 · International Research Journal of Modernization in Engineering Technology and Science
  16. SARS-CoV-2 and variants: Alternative therapies to avert COVID-19
    Birbal Singh, Gorakh Mal, Rinku Sharma, Gauri Jairath, Devi Gopinath, Ajayta Rialch · 2024 · Elsevier eBooks
  17. Human Microbiome, Virome, and Microbial Therapies Against COVID-19
    Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, Francesco Marotta · 2024 · Springer eBooks
  18. Anti-inflammatory protective effect of cannabidiol extracted from Cannabis sativa L. (hemp) against SARS-CoV-2 infection: A review of the literature
    Victor Ludeña-Meléndez, Harold Jiménez-Álvarez, Danna Laiza-Pajilla, Paula Ishikawa-Arias, Ana Gutiérrez-Guerrero, Leonardo Ledesma Chavarría, Jorge L Campos-Reyna · 2024 · Revista Médica de Trujillo
  19. Croton olifgandrus Pierre and Hutch Compounds Reverse HIV-1 Viral Latency
    Ian Edwin Cock · 2025 · Pharmacognosy Communications
  20. Nature is the world’s original pharmacy – returning to medicine’s roots could help fill drug discovery gaps
    Ashu Tripathi · 2022
  21. Adjunctive Therapies for Long COVID: An Evidence-Based Integrative Approach
    Bill Reddy · 2025 · Integrative Medicine Reports
  22. Additional file 1 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  23. Additional file 6 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  24. Additional file 5 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  25. Additional file 4 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  26. Additional file 2 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  27. Additional file 3 of SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City
    Maribel Soto-Nava, Vanessa Dávila‐Conn, Juan P. Venancio-Rocha, Pedro García‐Esparza, Daniela Tapia‐Trejo, Ramón Hernández‐Juan, Eduardo Zarza-Sánchez, Akio Murakami-Ogasawara, Santiago Ávila‐Ríos · 2024 · Figshare
  28. Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs
    Monique M. Koll, Robert Menardi, Daniel Hughes, Wayne S. Schwark, Joseph J. Wakshlag · 2026 · Frontiers in Veterinary Science
  29. Selected Cannabinoids, Cannabimimetic Agents and Artemisia Combinations as Theoretical Adjunct Strategies Against COVID-19
    Harry Chiririwa · 2026 · Pharmaceuticals
  30. Cannabis sativa chemotypes modulate TLR-associated innate immune gene expression and reduce BoAHV-1 replication in bovine cells
    Mercedes Burucúa, Milagros Junco, Silvina Quintana, Natalia Plá, Sandra E. Perez, Silvana Lorena Colman, Maia Solange Marin · 2026 · Molecular Immunology
  31. A Survey of Cannabigerol User’s Patterns of Use, Perceived Efficacy and Satisfaction
    Erika T. H. Lutz, Dustin Sulak, Leigh Vinocur, Ethan B. Russo, Carrie Cuttler · 2026 · Journal of Psychoactive Drugs
  32. BindingDB Entry 50019281: N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R).
    BindingDB · 2024 · UC San Diego
  33. BindingDB Entry 50018324: Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach.
    BindingDB · 2024 · UC San Diego
  34. BindingDB Entry 50023456: How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents.
    BindingDB · 2026 · UC San Diego
  35. BindingDB Entry 50019172: Development of
    BindingDB · 2024 · UC San Diego